These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10028450)

  • 1. The utility of ANCA and ASCA in inflammatory bowel disease.
    Targan SR
    Inflamm Bowel Dis; 1999 Feb; 5(1):61-3; discussion 66-7. PubMed ID: 10028450
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of anti-neutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibodies (ASCA) in inflammatory bowel disease].
    Gisbert JP; Gomollón F; Maté J; Pajares JM
    Gastroenterol Hepatol; 2003 May; 26(5):312-24. PubMed ID: 12732107
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease.
    Damoiseaux JG; Bouten B; Linders AM; Austen J; Roozendaal C; Russel MG; Forget PP; Tervaert JW
    J Clin Immunol; 2002 Sep; 22(5):281-8. PubMed ID: 12405161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of pANCA (antineutrophil cytoplasmic antibodies) and ASCA (anti-saccharomyces cerevisiae) in screening for IBD in young children.
    Kugathasan S; Werlin SL
    Inflamm Bowel Dis; 1999 Nov; 5(4):283-4. PubMed ID: 10579122
    [No Abstract]   [Full Text] [Related]  

  • 6. Serological markers in inflammatory bowel diseases.
    Reumaux D; Sendid B; Poulain D; Duthilleul P; Dewit O; Colombel JF
    Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):19-35. PubMed ID: 12617880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
    Quinton JF; Sendid B; Reumaux D; Duthilleul P; Cortot A; Grandbastien B; Charrier G; Targan SR; Colombel JF; Poulain D
    Gut; 1998 Jun; 42(6):788-91. PubMed ID: 9691915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of the detection of antibodies in the serum for diagnosis and treatment of inflammatory bowel disease.
    Rutgeerts P; Vermeire S
    Gastroenterology; 1998 Oct; 115(4):1006-9. PubMed ID: 9786723
    [No Abstract]   [Full Text] [Related]  

  • 9. The anti-Saccharomyces cerevisiae antibody assay in a province-wide practice: accurate in identifying cases of Crohn's disease and predicting inflammatory disease.
    Kaila B; Orr K; Bernstein CN
    Can J Gastroenterol; 2005 Dec; 19(12):717-21. PubMed ID: 16341311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of Behcet's disease from inflammatory bowel diseases: anti-Saccharomyces cerevisiae antibody and anti-neutrophilic cytoplasmic antibody.
    Filik L; Biyikoglu I
    World J Gastroenterol; 2008 Dec; 14(47):7271. PubMed ID: 19084948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Initial experience with detection of Saccharomyces cerevisiae antibodies in patients with primary nonspecific inflammatory bowel disease].
    Malícková K; Janatková I; Fucíková T; Adamec S; Lukás M
    Epidemiol Mikrobiol Imunol; 2001 Aug; 50(3):131-5. PubMed ID: 11550421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic role of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in pediatric inflammatory bowel disease].
    Kim JE; Kim KS; Seo JK
    Korean J Gastroenterol; 2003 Oct; 42(4):297-302. PubMed ID: 14634349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study.
    Desplat-Jégo S; Johanet C; Escande A; Goetz J; Fabien N; Olsson N; Ballot E; Sarles J; Baudon JJ; Grimaud JC; Veyrac M; Chamouard P; Humbel RL
    World J Gastroenterol; 2007 Apr; 13(16):2312-8. PubMed ID: 17511029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae mannan antibodies: new biological tools for diagnosis of inflammatory bowel disease].
    Bourreille A; Doubremelle M; Colombel JF
    Rev Med Interne; 2003 Mar; 24(3):147-50. PubMed ID: 12657435
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological markers anti-saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: a helpful diagnostic tool.
    Montanelli A; Mainardi E; Vagni A; Villanacci V; Zambelli C; Cestari R; Cengia P; Minelli L; Missale G
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):201-7. PubMed ID: 15990710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease.
    Canani RB; de Horatio LT; Terrin G; Romano MT; Miele E; Staiano A; Rapacciuolo L; Polito G; Bisesti V; Manguso F; Vallone G; Sodano A; Troncone R
    J Pediatr Gastroenterol Nutr; 2006 Jan; 42(1):9-15. PubMed ID: 16385247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease.
    Dubinsky MC; Ofman JJ; Urman M; Targan SR; Seidman EG
    Am J Gastroenterol; 2001 Mar; 96(3):758-65. PubMed ID: 11280547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnosis of chronic inflammatory bowel diseases. Value of determination of autoantibodies pANCA, ASCA AND PAB (perinuclear antineutrophil cytoplasmic antibody, antibody against Saccharomyces cerevisiae, antibody against pancreas)].
    Seibold F; Hufnagl R; Scheurlen M
    Fortschr Med; 1999 Feb; 117(6):42-3. PubMed ID: 10095303
    [No Abstract]   [Full Text] [Related]  

  • 19. Serological markers in inflammatory bowel disease: the pros and cons.
    Lerner A; Shoenfeld Y
    Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):103-5. PubMed ID: 11981332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serologic testing in inflammatory bowel disease: its value in indeterminate colitis.
    Papadakis KA; Targan SR
    Curr Gastroenterol Rep; 1999 Dec; 1(6):482-5. PubMed ID: 10980990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.